ArticleDiabetologia2023

High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment.

Emily K Sims et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.